Drug intelligence / Profile preview

Prolact HM

Development stage
Unknown
Lead developer
Prolacta Bioscience
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Prolact HM is a pasteurized human milk product manufactured by Prolacta Bioscience. It is intended for use as a nutritional source when mother’s own milk is unavailable, particularly in neonatal intensive care settings. The product consists of 100% donor human milk that has been screened for drugs and infectious agents, then pasteurized to reduce pathogenic viruses (such as HIV, HBV, HCV) and bacteria (including E. coli, S. aureus, Klebsiella species). Prolact HM provides at least 67 kcal per 100 mL but contains no added minerals or fortifiers; it is nutritionally incomplete and may require supplementation with vitamins and iron depending on the infant's needs. The primary indication is for feeding premature or critically ill infants who cannot receive their mother's own breast milk[1].

Brand names
Prolact HM
Other names
Donor breast milkPasteurized donor human milk
02

Targets

ADRA1A (α1A)HTR2A (Serotonin receptor 5-HT2A)DRD3 (Dopamine receptor D3)DRD2 (Dopamine D2 Receptor)HTR2B (5-Hydroxytryptamine Receptor 2B)DRD4 (Dopamine D4 Receptor)DRD1 (Dopamine D1 Receptor)

Beyond the preview

Go deeper on Prolact HM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolact HM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call